Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Zymergen Inc.
  6. News
  7. Summary
    ZY   US98985X1000

ZYMERGEN INC.

(ZY)
  Report
Real-time Estimate Cboe BZX  -  05/17 03:00:10 pm EDT
1.425 USD   -5.00%
05/12ZYMERGEN INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
05/12ZYMERGEN : Q1 Earnings Snapshot
AQ
05/12TRANSCRIPT : Zymergen Inc., Q1 2022 Earnings Call, May 12, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Zymergen Launches Drug Discovery Unit

01/10/2022 | 03:49am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about ZYMERGEN INC.
05/12ZYMERGEN INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
05/12ZYMERGEN : Q1 Earnings Snapshot
AQ
05/12TRANSCRIPT : Zymergen Inc., Q1 2022 Earnings Call, May 12, 2022
CI
05/12Earnings Flash (ZY) ZYMERGEN Reports Q1 Revenue $4.8M, vs. Street Est of $3.34M
MT
05/12Zymergen Reports Preliminary First Quarter 2022 Financial Results
AQ
05/12Zymergen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/10TRANSCRIPT : Zymergen Inc. Presents at Bank of America 2022 Healthcare Conference, May-10-..
CI
04/29Zymergen to Participate in the BofA Securities 2022 Healthcare Conference
AQ
04/13Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022
AQ
04/13Goldman Sachs Adjusts Zymergen's Price Target to $4 from $6, Keeps Neutral Rating
MT
More news
Analyst Recommendations on ZYMERGEN INC.
More recommendations
Financials (USD)
Sales 2022 13,4 M - -
Net income 2022 -294 M - -
Net cash 2022 91,0 M - -
P/E ratio 2022 -0,51x
Yield 2022 -
Capitalization 155 M 155 M -
EV / Sales 2022 4,75x
EV / Sales 2023 5,10x
Nbr of Employees 505
Free-Float 92,5%
Chart ZYMERGEN INC.
Duration : Period :
Zymergen Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZYMERGEN INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Last Close Price 1,50 $
Average target price 3,38 $
Spread / Average Target 125%
EPS Revisions
Managers and Directors
Jay T. Flatley Chairman & Chief Executive Officer
Enakshi Singh Chief Financial Officer
Zachariah Serber Director & Chief Science Officer
Rohit Sharma Independent Director
Matthew Ocko Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ZYMERGEN INC.-77.58%155
SHIN-ETSU CHEMICAL CO., LTD-9.81%57 803
BASF SE-20.21%46 334
DUPONT DE NEMOURS, INC.-20.61%32 612
SASOL LIMITED53.41%15 415
FMC CORPORATION6.49%14 737